Cardiosense, a Chicago, IL-based digital health company, raised $15.1M in Series A funding.
The round was co-led by Broadview Ventures and Hatteras Venture Partners, with participation from Laerdal Million Lives Fund, OSF Ventures, UnityPoint Health Ventures, and Portal Innovations. In connection with the investment, Daniel Gottlieb and Jeff Terrell from Broadview Ventures and Hatteras Venture Partners, respectively will join Cardiosense’s Board of Directors.
The company intends to use the funds to support team expansion, accelerate product development, and fund an expansive heart failure study.
Led by CEO Amit Gupta, Cardiosense is a health company building a physiological waveform AI platform to develop predictive biomarkers to detect and manage cardiac disease. The company has developed a suite of novel digital tools, multi-sensor devices, and analysis algorithms to detect early signs of cardiovascular disease, inform personalized therapy, and improve patient outcomes. Cardiosense’s clinical application focuses on improving the management of congestive heart failure (CHF), a condition that affects more than 6 million people in the US and is expected to cost the healthcare system more than $70 billion annually by 2030.
FinSMEs
09/12/2022